- GlobeNewswire•2 days ago
CARLSBAD, Calif., April 25, 2017-- International Stem Cell Corporation, a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced ...
- Capital Cube•22 days ago
Categories: Yahoo FinanceGet free summary analysis International Stem Cell Corp. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 1.69 million, Net Earnings of USD 2.16 million. Gross margins widened from 70.53% to 71.18% compared to the same period last year, operating (EBITDA) margins now -62.96% from -42.97%. Change in ... Read more (Read more...)
- GlobeNewswire•22 days ago
CARLSBAD, Calif., April 05, 2017-- International Stem Cell Corporation, a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today ...
ISCO : Summary for INTL STEM CELL CORP - Yahoo Finance
International Stem Cell Corporation (ISCO)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.75 - 1.75|
|52 Week Range||0.65 - 2.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|